Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars
Teva Pharmaceutical Industries Ltd., the biggest seller of Adderall in the US, has been experiencing “supply disruptions” of the popular ADHD drug at a time when demand is at all-time highs, a spokesperson for the company said.
Other Articles in this Edition
What is adult ADHD and how to treat it – The Conversation Weekly podcast transcript
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars
Pediatric ADHD, Psychiatric Disorders Medication Lowers Substance Misuse Risk
Researchers characterize a novel gene likely to cause neurological disorders in humans
As children’s ADHD diagnoses rise, parents discover they have it, too
Longitudinal Study of Sleep and ADHD Symptoms
Telehealth Has Failed ADHD Patients, But They Aren’t Giving Up
“I Made My ADHD Into My Strength”: Understanding The Link Between Rap & Neurodivergence